FDA Annual Registration Renewal: What Medical Device Companies Must Know Before December 31

The Clock Is Ticking: FDA Annual Registration Is Not Optional

Every year, between October 1 and December 31, medical device establishments registered with the FDA must renew their registration for the following fiscal year. This is not a formality. Under 21 CFR Part 807, failure to renew your establishment registration on time renders your facility legally unregistered — and operating an unregistered establishment is a prohibited act under Section 301(p) of the Federal Food, Drug, and Cosmetic Act (FD&C Act). For startups and small-to-mid-sized device companies, the downstream consequences can be severe and, frankly, avoidable.

This post breaks down exactly what you need to do, when you need to do it, how much it costs, and what happens if the deadline slips through the cracks.

Who Is Required to Register and List?

If your establishment is involved in the manufacture, preparation, propagation, compounding, assembly, or processing of a device intended for human use and distributed in the United States, you are required to register under 21 CFR 807.20. This includes domestic and foreign establishments. Device listing — identifying which devices your establishment makes — is a companion requirement under 21 CFR 807.25 and must be kept current as well.

Exemptions exist but are narrow. Certain component manufacturers, licensed practitioners, and specific distributor types may qualify. If you are unsure whether your establishment qualifies for an exemption, do not assume — confirm with a qualified regulatory consultant before you skip the process.

The October 1 to December 31 Renewal Window: What Actually Happens

The FDA fiscal year runs from October 1 through September 30. Establishments must renew their registration each year during the October 1 to December 31 window via the FDA Unified Registration and Listing System (FURLS), accessed through the FDA Industry Systems portal.

During renewal, you are required to:

• Confirm or update establishment information, including owner/operator details and U.S. agent information for foreign facilities
• Review and update your device listings — adding new devices, modifying existing entries, or removing discontinued products
• Pay the annual establishment registration user fee, which is mandated under Section 738(a)(3) of the FD&C Act and set annually by the FDA

For fiscal year 2025, the standard registration fee was $6,493 per establishment. Fee amounts are published annually in the Federal Register, typically in August or September, and can change year over year based on statutory adjustments. Small businesses that meet the FDA's definition under 21 CFR 807.3(r) may qualify for a reduced fee — but that qualification must be affirmatively established and is not automatically applied.

What Happens If You Miss the December 31 Deadline?

This is where many companies underestimate the risk. If your establishment registration lapses, the legal and operational consequences are real and immediate.

1. Your Establishment Becomes Unregistered

FDA's registration database is publicly searchable. Distributors, hospital systems, group purchasing organizations, and international regulatory bodies routinely verify supplier registration status. An unregistered status can trigger contract holds, purchase order cancellations, and failed supplier qualification audits — all of which hit revenue directly.

2. Shipment Detention and Import Alerts

For foreign establishments, failure to register or renew can result in devices being detained at the U.S. border. FDA has authority under Section 801(a) of the FD&C Act to refuse admission to devices from unregistered foreign facilities. Even one detained shipment can disrupt your entire U.S. commercial operation.

3. Warning Letters and Enforcement Action

FDA can — and does — issue Warning Letters citing failure to register or maintain current registration as a violation. A Warning Letter is public, indexed on FDA's website, and can affect investor confidence, M&A due diligence, and existing distributor relationships. In more serious scenarios, failure to register can be cited as part of a broader enforcement action.

4. Disruption to 510(k) and PMA Submissions

If you have a pending 510(k) or PMA application, an unregistered establishment can complicate or delay FDA review. FDA reviewers cross-reference establishment registration status during premarket review.

Practical Steps to Stay Ahead of the Deadline

• Set a calendar reminder for October 1 — do not wait until late December
• Confirm your FURLS account credentials are current and that the right personnel have access well before October
• Review your device listings now — renewal is an ideal time to clean up discontinued products or add recently cleared devices
• Verify your fee amount in the Federal Register notice published that August or September
• For foreign establishments, confirm your U.S. agent designation is current under 21 CFR 807.40
• Document your renewal confirmation number and retain it as part of your quality records

A Note on Device Listing Accuracy

Annual registration renewal is also your annual checkpoint for device listing accuracy. Under 21 CFR 807.30, establishments must update device listings within 30 days of a change. In practice, many companies accumulate discrepancies over time. Use the renewal window to reconcile your listed devices against your actual product portfolio. Inaccurate listings are an FDA inspection finding waiting to happen.

Do Not Treat This as Administrative Noise

FDA annual registration renewal is one of the most straightforward compliance requirements in device regulation — but it carries disproportionate risk when neglected. For companies in growth mode, juggling product development, clinical work, and commercial scale-up, it is exactly the type of recurring deadline that falls through the cracks without a systematic process in place.

At ADB Consulting and CRO Inc., we help medical device companies build the regulatory infrastructure to stay ahead of requirements like this — not react to them after the damage is done. Whether you need support managing your annual registration, preparing for an FDA inspection, or navigating a premarket submission, our team is ready to help.

Book a free discovery call with Andre Butler at adbccro.com and find out how ADB Consulting and CRO Inc. can keep your regulatory program on track — before a missed deadline becomes a crisis.

If this applies to your program, our Device Registration service walks through the process in detail.